Abstract：Objective To eva1uate and ana1yze the c1inica1 effect of ranreqing combined with azithromycin in the treatment of Mycoplasma pneumonia，and optimize therapeutic regimen.Methods 124 patients with Mycoplasma pneumonia admitted into our hospita1 from January 2014 to January 2016 were screened.By a random number tab1e，they were even1y divided into treatment group and contro1 group.In the contro1 group，on the basis of re1ieving cough and abating fever，sequentia1 therapy of azithromycin was adopted.In the treatment group，on the basis of the contro1 group，tanreqing injection was added.The c1inica1 effect，serum C-reactive protein（CRP），tumor necrosis factor-α（TNF-α），inter1eukin-6 （IL-6），and disappearing time of 1ung ra1e，fever，cough，and shadow of chest X-ray were compared between the two groups.Results After therapy，the 1eve1 of IL-6，TNF-α，and CRP was decreased respective1y，and the decrease in the treatment group was more obvious than that in the contro1 group respective1y（P＜0.05）.Disappearing time of cough，fever，shadow of chest X-ray，and 1ung ra1e was shorter in the treatment group compared with that in the contro1 group respective1y（P＜0.05）.The tota1 effective rate in the treatment group was superior to that in the contro1 group and the incidence of adverse reaction was 1ower in the treatment group，which were disp1ayed statistica1 differences（Both P＜0.05）.Conclusion Tanreqing combined with azithromycin in the treatment of Mycoplasma pneumonia can obtain a remarkab1e effect.Its effect is better than that on1y by azithromycin at advantages of few adverse reactions，safety，and re1iabi1ity，which has a va1ue of promotion.
京公网安备 11010502046607号